LENNAR CORP-A (LEN) Fundamental Analysis & Valuation

NYSE:LENUS5260571048

Current stock price

87.89 USD
+1.4 (+1.62%)
Last:

This LEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. LEN Profitability Analysis

1.1 Basic Checks

  • In the past year LEN was profitable.
  • In the past year LEN had a positive cash flow from operations.
  • Each year in the past 5 years LEN has been profitable.
  • LEN had a positive operating cash flow in each of the past 5 years.
LEN Yearly Net Income VS EBIT VS OCF VS FCFLEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • LEN has a better Return On Assets (5.98%) than 65.00% of its industry peers.
  • LEN has a Return On Equity of 9.37%. This is comparable to the rest of the industry: LEN outperforms 58.33% of its industry peers.
  • LEN has a Return On Invested Capital of 6.47%. This is comparable to the rest of the industry: LEN outperforms 50.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LEN is in line with the industry average of 9.17%.
Industry RankSector Rank
ROA 5.98%
ROE 9.37%
ROIC 6.47%
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
LEN Yearly ROA, ROE, ROICLEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • LEN has a Profit Margin of 6.02%. This is in the better half of the industry: LEN outperforms 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of LEN has declined.
  • LEN has a Operating Margin (8.09%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of LEN has declined.
  • The Gross Margin of LEN (10.38%) is worse than 95.00% of its industry peers.
  • In the last couple of years the Gross Margin of LEN has declined.
Industry RankSector Rank
OM 8.09%
PM (TTM) 6.02%
GM 10.38%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
LEN Yearly Profit, Operating, Gross MarginsLEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

6

2. LEN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LEN is creating some value.
  • LEN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LEN has less shares outstanding
  • LEN has a worse debt/assets ratio than last year.
LEN Yearly Shares OutstandingLEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LEN Yearly Total Debt VS Total AssetsLEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • LEN has an Altman-Z score of 3.72. This indicates that LEN is financially healthy and has little risk of bankruptcy at the moment.
  • LEN's Altman-Z score of 3.72 is fine compared to the rest of the industry. LEN outperforms 63.33% of its industry peers.
  • The Debt to FCF ratio of LEN is 208.46, which is on the high side as it means it would take LEN, 208.46 years of fcf income to pay off all of its debts.
  • LEN has a Debt to FCF ratio of 208.46. This is in the lower half of the industry: LEN underperforms 66.67% of its industry peers.
  • LEN has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • LEN's Debt to Equity ratio of 0.27 is in line compared to the rest of the industry. LEN outperforms 53.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 208.46
Altman-Z 3.72
ROIC/WACC0.73
WACC8.9%
LEN Yearly LT Debt VS Equity VS FCFLEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • LEN has a Current Ratio of 8.22. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 8.22, LEN belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
  • LEN has a Quick Ratio of 2.52. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.52, LEN belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.22
Quick Ratio 2.52
LEN Yearly Current Assets VS Current LiabilitesLEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. LEN Growth Analysis

3.1 Past

  • LEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.31%.
  • LEN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.33% yearly.
  • Looking at the last year, LEN shows a decrease in Revenue. The Revenue has decreased by -3.54% in the last year.
  • LEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.74% yearly.
EPS 1Y (TTM)-49.31%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.55%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-13.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LEN will show a small growth in Revenue. The Revenue will grow by 7.26% on average per year.
EPS Next Y-15.56%
EPS Next 2Y2.33%
EPS Next 3Y10.78%
EPS Next 5Y25.99%
Revenue Next Year-2.92%
Revenue Next 2Y0.68%
Revenue Next 3Y3.38%
Revenue Next 5Y7.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LEN Yearly Revenue VS EstimatesLEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
LEN Yearly EPS VS EstimatesLEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

4

4. LEN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 12.63, which indicates a correct valuation of LEN.
  • LEN's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of LEN to the average of the S&P500 Index (26.17), we can say LEN is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.50 indicates a reasonable valuation of LEN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LEN indicates a somewhat cheap valuation: LEN is cheaper than 71.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, LEN is valued rather cheaply.
Industry RankSector Rank
PE 12.63
Fwd PE 10.5
LEN Price Earnings VS Forward Price EarningsLEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LEN is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, LEN is valued a bit more expensive than 68.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 772.21
EV/EBITDA 8.11
LEN Per share dataLEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)38.43
EPS Next 2Y2.33%
EPS Next 3Y10.78%

6

5. LEN Dividend Analysis

5.1 Amount

  • LEN has a Yearly Dividend Yield of 2.22%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.41, LEN pays a bit more dividend than its industry peers.
  • LEN's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

  • On average, the dividend of LEN grows each year by 26.65%, which is quite nice.
  • LEN has paid a dividend for at least 10 years, which is a reliable track record.
  • LEN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)26.65%
Div Incr Years0
Div Non Decr Years16
LEN Yearly Dividends per shareLEN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 25.31% of the earnings are spent on dividend by LEN. This is a low number and sustainable payout ratio.
  • The dividend of LEN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP25.31%
EPS Next 2Y2.33%
EPS Next 3Y10.78%
LEN Yearly Income VS Free CF VS DividendLEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
LEN Dividend Payout.LEN Dividend Payout, showing the Payout Ratio.LEN Dividend Payout.PayoutRetained Earnings

LEN Fundamentals: All Metrics, Ratios and Statistics

LENNAR CORP-A

NYSE:LEN (4/6/2026, 12:33:04 PM)

87.89

+1.4 (+1.62%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-12
Earnings (Next)06-15
Inst Owners93.57%
Inst Owner Change0%
Ins Owners0.29%
Ins Owner Change1.65%
Market Cap21.76B
Revenue(TTM)34.19B
Net Income(TTM)2.06B
Analysts51.85
Price Target102.16 (16.24%)
Short Float %4.94%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend2.02
Dividend Growth(5Y)26.65%
DP25.31%
Div Incr Years0
Div Non Decr Years16
Ex-Date02-04
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.91%
Min EPS beat(2)-13.73%
Max EPS beat(2)7.91%
EPS beat(4)2
Avg EPS beat(4)-0.42%
Min EPS beat(4)-13.73%
Max EPS beat(4)11.86%
EPS beat(8)5
Avg EPS beat(8)4.01%
EPS beat(12)9
Avg EPS beat(12)8.75%
EPS beat(16)11
Avg EPS beat(16)4.95%
Revenue beat(2)1
Avg Revenue beat(2)-0.1%
Min Revenue beat(2)-3.05%
Max Revenue beat(2)2.85%
Revenue beat(4)3
Avg Revenue beat(4)0.78%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)2.85%
Revenue beat(8)5
Avg Revenue beat(8)0.29%
Revenue beat(12)9
Avg Revenue beat(12)2.51%
Revenue beat(16)11
Avg Revenue beat(16)1.94%
PT rev (1m)-8.07%
PT rev (3m)-13.65%
EPS NQ rev (1m)-0.64%
EPS NQ rev (3m)-0.89%
EPS NY rev (1m)-2.06%
EPS NY rev (3m)-12.14%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.29%
Revenue NY rev (1m)-1.26%
Revenue NY rev (3m)-3.33%
Valuation
Industry RankSector Rank
PE 12.63
Fwd PE 10.5
P/S 0.64
P/FCF 772.21
P/OCF 100.38
P/B 0.99
P/tB 1.19
EV/EBITDA 8.11
EPS(TTM)6.96
EY7.92%
EPS(NY)8.37
Fwd EY9.52%
FCF(TTM)0.11
FCFY0.13%
OCF(TTM)0.88
OCFY1%
SpS138.06
BVpS88.68
TBVpS74.01
PEG (NY)N/A
PEG (5Y)38.43
Graham Number117.85
Profitability
Industry RankSector Rank
ROA 5.98%
ROE 9.37%
ROCE 8.55%
ROIC 6.47%
ROICexc 7.33%
ROICexgc 12.52%
OM 8.09%
PM (TTM) 6.02%
GM 10.38%
FCFM 0.08%
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
ROICexc(3y)11.54%
ROICexc(5y)13.41%
ROICexgc(3y)16.37%
ROICexgc(5y)17.4%
ROCE(3y)12.94%
ROCE(5y)15.31%
ROICexgc growth 3Y-14.19%
ROICexgc growth 5Y2.33%
ROICexc growth 3Y-24.42%
ROICexc growth 5Y-4.96%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 208.46
Debt/EBITDA 2.03
Cap/Depr 140.44%
Cap/Sales 0.55%
Interest Coverage 55.18
Cash Conversion 7.47%
Profit Quality 1.37%
Current Ratio 8.22
Quick Ratio 2.52
Altman-Z 3.72
F-Score5
WACC8.9%
ROIC/WACC0.73
Cap/Depr(3y)126.5%
Cap/Depr(5y)104.2%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.35%
Profit Quality(3y)63.09%
Profit Quality(5y)63.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-49.31%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.55%
EPS Next Y-15.56%
EPS Next 2Y2.33%
EPS Next 3Y10.78%
EPS Next 5Y25.99%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-13.26%
Revenue Next Year-2.92%
Revenue Next 2Y0.68%
Revenue Next 3Y3.38%
Revenue Next 5Y7.26%
EBIT growth 1Y-46.35%
EBIT growth 3Y-26.63%
EBIT growth 5Y-4.23%
EBIT Next Year-17.49%
EBIT Next 3Y10.01%
EBIT Next 5Y18.06%
FCF growth 1Y-98.74%
FCF growth 3Y-79.37%
FCF growth 5Y-63.1%
OCF growth 1Y-90.98%
OCF growth 3Y-59.51%
OCF growth 5Y-44.7%

LENNAR CORP-A / LEN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LENNAR CORP-A (LEN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LEN.


What is the valuation status for LEN stock?

ChartMill assigns a valuation rating of 4 / 10 to LENNAR CORP-A (LEN). This can be considered as Fairly Valued.


Can you provide the profitability details for LENNAR CORP-A?

LENNAR CORP-A (LEN) has a profitability rating of 4 / 10.


What is the financial health of LENNAR CORP-A (LEN) stock?

The financial health rating of LENNAR CORP-A (LEN) is 6 / 10.


Can you provide the expected EPS growth for LEN stock?

The Earnings per Share (EPS) of LENNAR CORP-A (LEN) is expected to decline by -15.56% in the next year.